CONAVI MEDICAL CORP (CNVI.CA) Stock Income Statement
TSX-V:CNVI - TSX Venture Exchange - CA2059531020 - Common Stock - Currency: CAD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 25.35M | 0.00 | 28.89M | 20.00M | 0.00 | |||
| Operating Expenses | 12.48M | 64.37M | 73.44M | 15.80M | 59.27M | |||
| Research and Development | 461.50K | 47.45M | 54.57M | 7.94M | 51.42M | |||
| Selling, General, and Administrative Expenses | 11.75M | 15.68M | 17.86M | 7.63M | 7.81M | |||
| Operating Income | 12.87M | -64.37M | -44.55M | 4.20M | -59.27M | |||
| Interest Income/Expense | 665.70K | 6.45M | 22.40M | -29.04M | 19.46M | |||
| Other Income/Expense | 151.00K | 0.00 | 869.80K | -1.82M | -2.10M | |||
| Non Recurring Items | -3.99M | -3.33M | 0.00 | 2.47M | N/A | |||
| Income Before Taxes | 10.03M | -61.24M | -21.28M | -24.18M | -41.91M | |||
| Income Tax | 34.50K | -80.50K | 80.50K | N/A | N/A | |||
| Net Income | 10.00M | -61.16M | -21.36M | -24.18M | -41.91M | |||
| EBITDA | 13.13M | -63.13M | -43.55M | 4.44M | -59.24M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.09 | -0.55 | -0.20 | -0.36 | -1.37 | |||
| Statistics | ||||||||
| Profit Margin | 39.43% | N/A | -73.95% | -120.90% | N/A | |||
| Operating Profit Margin | 50.75% | N/A | -154.22% | 21.00% | N/A | |||
All data in CAD